Comparison of left ventricular reverse remodeling induced by cardiac contractility modulation and cardiac resynchronization therapy in heart failure patients with different QRS durations

International Journal of Cardiology

Volumn 167, Issue 3, 2013, Pages 889-893

  Zhang, Qing ^a,b   Chan, Yat Sun ^a   Liang, Yu Jia ^a,b   Fang, Fang ^a   Lam, Yat Yin ^a   Chan, Chin Pang ^a   Lee, Alex Pui Wei ^a   Chan, Karl Chi Yuen ^a   Wu, Eugene B ^a   Yu, Cheuk Man ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Cardiac contractility modulation; Cardiac resynchronization therapy; Reverse remodeling

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; SPIRONOLACTONE;

ADULT; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; FEMALE; HEART CONTRACTION; HEART FAILURE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART VENTRICLE REMODELING; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; QRS COMPLEX; TREATMENT OUTCOME;

CARDIAC CONTRACTILITY MODULATION; CARDIAC RESYNCHRONIZATION THERAPY; REVERSE REMODELING;

AGED; AGED, 80 AND OVER; CARDIAC RESYNCHRONIZATION THERAPY; COHORT STUDIES; FEMALE; HEART FAILURE; HEART RATE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR REMODELING;

EID: 84880918755     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.01.066     Document Type: Article

References (31)

1. W.T. Abraham, W.G. Fisher, and A.L. Smith Cardiac resynchronization in chronic heart failure N Engl J Med 346 24 2002 1845 1853
2. C.B. Brunckhorst, I. Shemer, Y. Mika, S.A. Ben Haim, and D. Burkhoff Cardiac contractility modulation by non-excitatory currents: studies in isolated cardiac muscle Eur J Heart Fail 8 1 2006 7 15
3. S. Mohri, K.L. He, and M. Dickstein Cardiac contractility modulation by electric currents applied during the refractory period Am J Physiol Heart Circ Physiol 282 5 2002 H1642 H1647
4. C. Pappone, S. Rosanio, and D. Burkhoff Cardiac contractility modulation by electric currents applied during the refractory period in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy Am J Cardiol 90 12 2002 1307 1313
5. M. Imai, S. Rastogi, and R.C. Gupta Therapy with cardiac contractility modulation electrical signals improves left ventricular function and remodeling in dogs with chronic heart failure J Am Coll Cardiol 49 21 2007 2120 2128
6. C. Pappone, G. Augello, and S. Rosanio First human chronic experience with cardiac contractility modulation by nonexcitatory electrical currents for treating systolic heart failure: mid-term safety and efficacy results from a multicenter study J Cardiovasc Electrophysiol 15 4 2004 418 427
7. T. Lawo, M. Borggrefe, and C. Butter Electrical signals applied during the absolute refractory period: an investigational treatment for advanced heart failure in patients with normal QRS duration J Am Coll Cardiol 46 12 2005 2229 2236
8. S.B. Neelagaru, J.E. Sanchez, and S.K. Lau Nonexcitatory, cardiac contractility modulation electrical impulses: feasibility study for advanced heart failure in patients with normal QRS duration Heart Rhythm 3 10 2006 1140 1147
9. M.M. Borggrefe, T. Lawo, and C. Butter Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure Eur Heart J 29 8 2008 1019 1028
10. C.M. Yu, J.Y. Chan, and Q. Zhang Impact of cardiac contractility modulation on left ventricular global and regional function and remodeling JACC Cardiovasc Imaging 2 12 2009 1341 1349
11. C.M. Yu, D.L. Hayes, and A. Auricchio Cardiac Resynchronization Therapy 2nd ed 2008 Wiley-Blackwell
12. C.M. Yu, G.B. Bleeker, and J.W. Fung Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy Circulation 112 11 2005 1580 1586
13. J.G. Cleland, J.C. Daubert, and E. Erdmann The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 352 15 2005 1539 1549
14. T.V. Salukhe, D.P. Francis, and R. Sutton Comparison of medical therapy, pacing and defibrillation in heart failure (COMPANION) trial terminated early; combined biventricular pacemaker-defibrillators reduce all-cause mortality and hospitalization Int J Cardiol 87 2-3 2003 119 120
15. S.A. Hunt, W.T. Abraham, and M.H. Chin focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 119 14 2009 e391 e479
16. C. Butter, E. Wellnhofer, M. Schlegl, G. Winbeck, E. Fleck, and H.N. Sabbah Enhanced inotropic state of the failing left ventricle by cardiac contractility modulation electrical signals is not associated with increased myocardial oxygen consumption J Card Fail 13 2 2007 137 142
17. E.S. Chung, A.R. Leon, and L. Tavazzi Results of the Predictors of Response to CRT (PROSPECT) trial Circulation 117 20 2008 2608 2616
18. M.S. Suffoletto, K. Dohi, M. Cannesson, S. Saba, and J. Gorcsan III Novel speckle-tracking radial strain from routine black-and-white echocardiographic images to quantify dyssynchrony and predict response to cardiac resynchronization therapy Circulation 113 7 2006 960 968
19. H.D. White, R.M. Norris, M.A. Brown, P.W. Brandt, R.M. Whitlock, and C.J. Wild Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction Circulation 76 1 1987 44 51
20. M.R. Bristow, E.M. Gilbert, and W.T. Abraham Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators Circulation 94 11 1996 2807 2816
21. W.J. Remme The Carvedilol and ACE-Inhibitor Remodelling Mild Heart Failure EvaluatioN trial (CARMEN) - rationale and design Cardiovasc Drugs Ther 15 1 2001 69 77
22. D.G. Kramer, T.A. Trikalinos, D.M. Kent, G.V. Antonopoulos, M.A. Konstam, and J.E. Udelson Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: a meta-analytic approach J Am Coll Cardiol 56 5 2010 392 406
23. H. Morita, G. Suzuki, and W. Haddad Long-term effects of non-excitatory cardiac contractility modulation electric signals on the progression of heart failure in dogs Eur J Heart Fail 6 2 2004 145 150
24. G. Stix, M. Borggrefe, and C. Wolpert Chronic electrical stimulation during the absolute refractory period of the myocardium improves severe heart failure Eur Heart J 25 8 2004 650 655
25. J. Winter, K.E. Brack, and G.A. Ng Cardiac contractility modulation in the treatment of heart failure: initial results and unanswered questions Eur J Heart Fail 13 7 2011 700 710
26. Q. Zhang, Y.T. Liu, and P.W. Lee Left ventricular systolic dyssynchrony is more common in acute decompensated than chronic stable heart failure with reduced ejection fraction J Am Coll Cardiol 55 10 (Supplement 1 2010 A34
27. G.Y. Cho, J.K. Song, and W.J. Park Mechanical dyssynchrony assessed by tissue Doppler imaging is a powerful predictor of mortality in congestive heart failure with normal QRS duration J Am Coll Cardiol 46 12 2005 2237 2243
28. C.M. Yu, J.W. Fung, and C.K. Chan Comparison of efficacy of reverse remodeling and clinical improvement for relatively narrow and wide QRS complexes after cardiac resynchronization therapy for heart failure J Cardiovasc Electrophysiol 15 9 2004 1058 1065
29. C. Daubert, M.R. Gold, and W.T. Abraham Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial J Am Coll Cardiol 54 20 2009 1837 1846
30. C. Linde, W.T. Abraham, M.R. Gold, S.M. St John, S. Ghio, and C. Daubert Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms J Am Coll Cardiol 52 23 2008 1834 1843
31. H. Nagele, S. Behrens, and C. Eisermann Cardiac contractility modulation in non-responders to cardiac resynchronization therapy Europace 10 12 2008 1375 1380